查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1950471

全球柔軟性胃腸內視鏡設備市場（按設備類型、內視鏡類型、技術、應用、最終用戶和銷售管道分類），2026-2032年預測

Flexible Gastrointestinal Endoscopic Devices Market by Device Type, Endoscopy Type, Technology, Applications, End Users, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，軟性胃腸內視鏡設備市場價值將達到 31.5 億美元，到 2026 年將成長至 34.8 億美元，到 2032 年將達到 62.5 億美元，複合年成長率為 10.28%。

關鍵市場統計數據
基準年 2025 31.5億美元
預計年份：2026年 34.8億美元
預測年份 2032 62.5億美元
複合年成長率 (%) 10.28%

隨著人們對安全性、易用性和經濟性的期望日益提高，現代化的、柔軟性的胃腸內視鏡設備正在重塑臨床工作流程和商業性重點。

柔軟性胃腸內視鏡設備如今在臨床需求、技術創新和醫療保健系統經濟的交匯點上發揮核心作用。這些設備旨在可視化和治療整個胃腸道的病變，已從簡單的診斷工具發展成為支持日益廣泛的治療性介入的多功能平台。因此，設備開發商、醫院系統、門診手術中心和門診診所必須在一個快速變化的生態系統中尋求平衡，在這個生態系統中，臨床療效、用戶人體工學、感染控制和總體擁有成本 (TCO) 等因素都需引起重視。

成像精度的顯著提高、一次性設備的廣泛應用、自動化以及數據驅動的工作流程等關鍵轉折點，正在重新定義內視鏡檢查的實踐和競爭格局。

柔軟性胃腸內視鏡裝置領域正經歷一系列變革，重塑臨床實務和市場競爭格局。高解析度成像技術和組織表徵技術等成像和光學技術的進步，提高了病灶檢出率和診斷信心。同時，動力插入機制和其他機械創新也改善了操作的人體工學和操作一致性，使臨床醫生能夠以更高的精度和更小的身體負擔完成更複雜的手術操作。

不斷變化的關稅政策和貿易趨勢對內視鏡價值鏈的策略影響：對供應鏈韌性、籌資策略和購買行為的影響

美國2025年預計的關稅調整和貿易政策轉變正促使人們對支持柔軟性胃腸內視鏡設備的整個供應鏈進行策略性重新評估。傳統上依賴跨境製造和零件採購的公司正面臨不斷上漲的進口關稅、更長的前置作業時間和日益複雜的行政流程。為此，許多製造商和經銷商正在探索各種方案，例如在免稅地區委託製造、近岸外包和垂直整合，以維持利潤率和供應的連續性。

從設備外形、手術目標、技術模式、臨床應用、使用者環境和分銷管道等方面進行全面的觀點，並與策略重點保持一致。

對市場區隔的深刻理解會影響產品開發和商業策略。依設備類型分類，市場包括大腸鏡、十二指腸鏡、小腸鏡和胃鏡，每種設備可進一步細分為一次性使用和可重複使用。這造就了獨特的臨床和操作應用場景，進而影響購買決策。根據內視鏡類型，設備可用於診斷和治療性介入。診斷應用場景可細分為切片檢查和影像檢查，而治療應用場景包括止血、息肉切除、支架置入和食道靜脈曲張結紮術，每項應用都需要與專用配件相容並確保操作的可靠性。

區域管理體制、臨床實踐模式和製造生態系統如何塑造全球市場中不同的應用路徑和商業策略

區域差異顯著影響著軟性胃腸內視鏡設備的研發、核准和應用。在美洲，法規結構和報銷模式側重於臨床療效和手術效率，而成熟的私人醫療機構市場和大規模的醫院網路則為高階可重複使用平台和實用的一次性解決方案都創造了機會。研發活動集中在領先的學術機構，這些機構往往是早期採用者和具有影響力的意見領袖，影響著全部區域的指南和採購路徑。

競爭動態和策略定位洞察，揭示產品系列、生產規模、臨床證據和服務模式如何決定市場領導地位。

柔軟性胃腸內視鏡器材的競爭格局由成熟的醫療技術領導者、專業器材公司和提供精準創新的敏捷型新創公司共同構成。競爭對手透過Start-Ups來區分彼此，這些產品組合突出了整合可視化功能和配件的綜合平台解決方案，或專注於拋棄式、增強型光學元件和電動插入技術的細分產品。那些優先考慮強力的臨床證據產生、簡化監管流程和可擴展生產能力的公司，持續降低了市場進入門檻，並建立了永續的客戶關係。

為行業領導者提供可操作的策略性舉措和營運重點，以確保韌性、加速產品應用並推動臨床差異化。

產業領導者必須採取果斷、有針對性的策略行動，將顛覆性趨勢轉化為永續優勢。首先，優先考慮模組化平台設計，以便快速更換一次性組件、先進成像模組和插入子系統。這將縮短增量升級的上市時間，並簡化監理申報流程。其次，實現生產和採購基礎多元化，納入區域契約製造製造商和替代供應商，以降低關稅波動和物流中斷帶來的風險。第三，投資於高品質、經同行評審的臨床研究，以證明診斷準確性、手術效率和安全性方面的實際改進，因為採購委員會越來越需要可靠的真實世界數據（RWE）。

我們採用穩健的多方面研究途徑，結合臨床見解、監管和專利分析以及基於情境的檢驗，為實際的策略決策提供支援。

我們的基礎調查方法整合了多方面的證據來源，以得出嚴謹而令人信服的結論。主要研究包括對臨床關鍵管理人員、採購經理、醫療設備技術經理和供應鏈高階主管進行結構化訪談和保密諮詢，以揭示營運挑戰、應用標準和服務期望。專家小組和顧問委員會為新興技術提供了臨床背景，並檢驗了流程和培訓要求的假設。我們將這些定性資料與來自同儕審查的臨床文獻、監管文件、專利概況和醫療設備註冊資料的二手資料進行三角驗證，以確保技術和效能聲明得到支持。

對臨床、營運和策略需求的綜合分析凸顯了整合產品、供應鏈和實證策略對於產生持久影響的重要性。

柔軟性胃腸內視鏡設備的整體發展格局呈現出技術快速進步與營運和監管審查日益嚴格的態勢。視覺化方法、插入機制和數據分析的進步提升了臨床應用能力，同時也引發了人們對消毒、供應穩定性和生命週期經濟性的思考。隨著醫療服務提供者和支付方越來越關注療效和效率，製造商必須在高性能設計、實用服務模式和多樣化的生產策略之間取得平衡。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依設備類型柔軟性胃腸內視鏡設備市場

  • 大腸鏡檢查
  • 十二指腸鏡
  • 腸鏡檢查
  • 胃鏡

第9章 依內視鏡類型柔軟性胃腸內視鏡設備市場

  • 診斷
    • 切片檢查
    • 影像診斷
  • 治療
    • 止血
    • 息肉切除術
    • 支架置入
    • 靜脈曲張結紮術

第10章 依技術柔軟性胃腸內視鏡設備市場

  • 插入技術
    • 電插入法
    • 標準插頁
  • 視覺化技術
    • 4K成像
    • 自動螢光精華
    • 高畫質
    • 窄頻成像

第11章 依應用分類的柔軟性胃腸內視鏡設備市場

  • 診斷影像
  • 去除異物
  • 出血控制
  • 息肉檢測
  • 狹窄擴張
  • 組織切片檢查

第12章 依最終用戶柔軟性胃腸內視鏡設備市場

  • 門診手術中心
  • 診所
  • 醫院

第13章柔軟性胃腸內視鏡設備市場（依銷售管道分類）

  • 直銷
  • 批發商
  • 電子商務

第14章 各地區柔軟性胃腸內視鏡設備市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章柔軟性胃腸內視鏡設備市場（按類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國柔軟性胃腸內視鏡設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

17. 美國柔軟性胃腸內視鏡設備市場

第18章 中國柔軟性胃腸內視鏡設備市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Ambu A/S
  • ATMOS MedizinTechnik GmbH & Co. KG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • ConMed Corporation
  • Cook Medical LLC
  • EndoMed Systems GmbH
  • Erbe Elektromedizin GmbH
  • Fujifilm Holdings Corporation
  • HOYA Corporation
  • Johnson & Johnson
  • KARL STORZ SE & Co. KG
  • Laborie Medical
  • Medtronic plc
  • Olympus Corporation
  • Richard Wolf GmbH
  • Smith & Nephew plc
  • Stryker Corporation
Product Code: MRR-4F7A6D4FD885

The Flexible Gastrointestinal Endoscopic Devices Market was valued at USD 3.15 billion in 2025 and is projected to grow to USD 3.48 billion in 2026, with a CAGR of 10.28%, reaching USD 6.25 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.15 billion
Estimated Year [2026] USD 3.48 billion
Forecast Year [2032] USD 6.25 billion
CAGR (%) 10.28%

How modern flexible gastrointestinal endoscopic devices reshape clinical workflows and commercial priorities amid evolving safety, usability, and economic expectations

Flexible gastrointestinal endoscopic devices now occupy a central role at the intersection of clinical need, technological innovation, and health system economics. These devices, designed to visualize and treat pathology throughout the tubular gastrointestinal tract, have evolved from solely diagnostic tools into multi-functional platforms that support a widening array of therapeutic interventions. As a result, device developers, hospital systems, ambulatory surgical centers, and outpatient clinics must navigate a rapidly changing ecosystem in which clinical efficacy, user ergonomics, infection control, and total cost of ownership compete for attention.

Clinicians increasingly demand instruments that improve lesion detection while reducing procedure time and operator fatigue. At the same time, hospital procurement teams emphasize lifecycle costs, sterilization workflows, and supply reliability. This dual pressure creates fertile ground for innovation across disposable and reusable models, enhanced visualization modalities, and insertion technologies that reduce variability and procedural risk. Regulatory agencies have concurrently tightened expectations for device reprocessing and post-market surveillance, driving greater transparency and compliance burdens for manufacturers and providers alike.

Consequently, strategic leaders should view endoscopic device development through a systems lens that incorporates clinical pathways, device interoperability, service models, and environmental impact. By aligning product design with the pragmatic requirements of end users and the evolving regulatory landscape, companies can both accelerate adoption and mitigate downstream operational friction. As stakeholders adapt, the market will reward solutions that balance clinical performance with pragmatic, scalable commercial models.

Key inflection points in imaging accuracy, single-use device adoption, automation, and data-driven workflows that are redefining endoscopy practice and competition

The landscape for flexible gastrointestinal endoscopic devices is experiencing a set of transformative shifts that are reshaping clinical practice and competitive dynamics. Advances in imaging and optics, such as higher-resolution modalities and tissue characterization techniques, have improved lesion detection and diagnostic confidence. Simultaneously, motorized insertion and other mechanical innovations are altering ergonomics and procedural consistency, enabling clinicians to undertake more complex interventions with greater precision and less physical strain.

Concurrently, single-use disposable platforms have emerged as a strategic response to infection prevention concerns and reprocessing constraints, prompting reassessment of clinical protocols and supply chain models. Artificial intelligence and computer-assisted detection are maturing from pilot projects into integrated workflow tools that prioritize suspicion areas and standardize reporting. In parallel, connectivity and data analytics are enabling remote proctoring, tele-endoscopy, and more systematic performance benchmarking across institutions.

Market dynamics are also changing in response to broader healthcare trends. Value-based care models emphasize outcomes and efficiency, encouraging adoption of technologies that demonstrably reduce repeat procedures and complications. Procurement teams are increasingly sophisticated, demanding evidence of real-world impact and predictable service economics. As a result, vendors must combine clinical evidence generation with flexible commercial arrangements and scalable manufacturing approaches. Taken together, these trends signify a pivot from incremental device improvement toward platform-level innovation and services that integrate devices into holistic clinical pathways.

Strategic consequences of evolving tariff policies and trade dynamics on supply chain resilience, sourcing strategies, and procurement behavior across the endoscopy value chain

Anticipated tariff changes and trade policy shifts in the United States for 2025 have catalyzed strategic reassessment across the supply chains that support flexible gastrointestinal endoscopic devices. Firms that historically relied on cross-border manufacturing and component sourcing are confronting higher import duties, longer lead times, and increased administrative complexity. In response, many manufacturers and distributors are evaluating options such as contract manufacturing in tariff-exempt jurisdictions, nearshoring, or vertical integration to preserve margin and continuity of supply.

These dynamics cascade into procurement behavior at hospitals, ambulatory surgical centers, and clinics. Purchasing teams respond to cost pressure by demanding greater transparency around landed costs, warranty terms, and post-market service commitments. Moreover, facilities place higher strategic value on suppliers that demonstrate diversified manufacturing footprints and proven contingency plans. For smaller innovators and start-ups, tariff volatility can be particularly disruptive, increasing barriers to entry and complicating clinical trial logistics for regulated devices.

Regulatory compliance and customs documentation have become operational priorities, since misclassification and paperwork errors can exacerbate delays and penalties. Meanwhile, clinical adoption may shift toward devices that can be sourced domestically or regionally, accelerating interest in single-use alternatives that simplify logistics and reprocessing burdens. In short, evolving tariff environments are not just cost events; they are strategic inflection points that influence manufacturing strategy, commercial partnerships, and long-term positioning in the endoscopy ecosystem.

Integrated segmentation perspectives that align device form factors, procedural intent, technology modalities, clinical applications, user settings, and distribution channels to strategic priorities

A nuanced understanding of how the market segments informs both product development and commercial strategy. Based on device type, the market includes colonoscopes, duodenoscopes, enteroscopes, and gastroscopes, and each of these is further differentiated across disposable and reusable formats, creating distinct clinical and operational use cases that influence purchasing decisions. Based on endoscopy type, devices support diagnostic procedures and therapeutic interventions, with diagnostic use cases further subdivided into biopsy and imaging, while therapeutic procedures encompass hemostasis, polypectomy, stent placement, and variceal ligation, each demanding specialized accessory compatibility and procedural reliability.

From a technology perspective, the landscape divides into insertion technology and visualization technology, where insertion options range from motorized insertion to standard manual techniques, and visualization spans 4K imaging, autofluorescence, high-definition, and narrow band imaging; these technological choices affect lesion detectability, workflow integration, and training requirements. Application-driven segmentation captures diagnostic imaging, foreign body removal, hemorrhage control, polyp detection, stricture dilation, and tissue biopsy, demonstrating that devices must be versatile enough to address both routine screening and complex interventional cases. End users include ambulatory surgical centers, clinics, and hospitals, each with distinct purchasing cycles, budget constraints, and procedural volumes that shape the economics of disposables versus reusable systems.

Finally, sales channels range from direct sales to distributor networks and e-commerce platforms, and channel strategy materially affects market access, service delivery, and aftermarket revenue. Together, these segmentation layers create a matrix of clinical needs and commercial levers; successful products align design features, evidence generation, and distribution approaches with the priority use cases and procurement realities of target end users, thereby accelerating adoption and ensuring operational sustainability.

How regional regulatory regimes, clinical practice patterns, and manufacturing ecosystems shape differentiated adoption pathways and commercial strategies across global markets

Regional variation strongly influences how flexible gastrointestinal endoscopic devices are developed, approved, and adopted. In the Americas, regulatory frameworks and reimbursement models put a premium on clinical outcomes and procedural efficiency, while a mature private provider market and substantial hospital networks create opportunities for both premium reusable platforms and pragmatic single-use solutions. Research and clinical trial activity is concentrated in major academic centers, which often act as early adopters and influential opinion leaders, shaping guidelines and procurement pathways across the region.

In Europe, Middle East & Africa, fragmented reimbursement systems and heterogeneous regulatory environments encourage flexible commercialization strategies that combine centralized evidence generation with region-specific market entry plans. Emerging markets within the region are price sensitive yet increasingly prioritize investments that reduce infection risk and operating room turnaround time, making single-use technologies and robust sterilization services particularly attractive. In contrast, established Western European systems emphasize long-term cost-effectiveness and environmental considerations, prompting manufacturers to address lifecycle impacts.

Asia-Pacific exhibits rapid adoption of advanced visualization and digital integration, driven by high procedure volumes, expanding private healthcare sectors, and active domestic manufacturing ecosystems. Local manufacturers and contract manufacturers play a significant role in supply chains, and regulatory pathways in several jurisdictions have shortened approval timelines for incremental device updates. Across these regions, differences in clinical practice patterns, reimbursement, and manufacturing capacity require nuanced go-to-market approaches that balance global platform consistency with tailored regional execution.

Competitive dynamics and strategic positioning insights that reveal how product portfolios, manufacturing scale, clinical evidence, and service models determine market leadership

The competitive environment for flexible gastrointestinal endoscopic devices is defined by a mix of established medtech leaders, specialist device firms, and agile startups bringing targeted innovations. Competitors differentiate through portfolios that emphasize either comprehensive platform solutions with integrated visualization and accessories or niche offerings focused on single-use disposables, enhanced optics, or motorized insertion technologies. Companies that have prioritized robust clinical evidence generation, streamlined regulatory pathways, and scalable manufacturing capabilities consistently reduce adoption friction and build durable customer relationships.

Strategic plays within the sector include vertical integration to secure critical components and post-sale services, licensing arrangements to accelerate technology pairing with complementary platforms, and partnerships with clinical centers for real-world evidence collection. Intellectual property positions around insertion mechanics, sterilization methods, and imaging enhancements serve as important barriers to entry, while open interoperability and software-enabled analytics are becoming key differentiators. Firms that invest in comprehensive training programs and service models that minimize downtime create stickier customer relationships, particularly among high-volume hospital systems and ambulatory surgical centers.

Emerging firms often focus on a narrow clinical pain point-such as reducing infection risk or improving polyp detection-and use that focused value proposition to secure footholds. As competition intensifies, the ability to combine clinical performance with reliable supply, regulatory clarity, and attractive commercial terms will determine which companies capture long-term value in the ecosystem.

Actionable strategic initiatives and operational priorities that industry leaders should implement to secure resilience, accelerate adoption, and drive clinical differentiation

Industry leaders must act decisively to translate disruptive trends into sustainable advantage through targeted strategic moves. First, prioritize modular platform design that allows rapid interchange of disposable components, advanced imaging modules, and insertion sub-systems; this reduces time-to-market for incremental upgrades and eases regulatory submissions. Second, diversify manufacturing and sourcing footprints to include regional contract manufacturers and contingency suppliers, thereby reducing exposure to tariff volatility and logistics disruptions. Third, invest in high-quality, peer-reviewed clinical studies that demonstrate tangible improvements in diagnostic yield, procedural efficiency, or safety outcomes, since procurement committees increasingly demand robust real-world evidence.

Fourth, develop flexible commercial models that blend direct sales with distributor partnerships and e-commerce channels, tailoring offerings to the specific needs of ambulatory surgical centers, clinics, and hospitals. Fifth, accelerate digital integration by embedding AI-assisted detection and procedure documentation tools into device workflows to enhance clinician productivity and support quality programs. Sixth, establish comprehensive post-market service and training programs to improve uptime and operator proficiency, which fosters longer-term relationships and aftermarket revenue. Seventh, engage proactively with regulatory bodies and standards-setting organizations to shape pragmatic reprocessing and device-safety expectations, helping to reduce uncertainty for both manufacturers and providers.

Finally, incorporate environmental and lifecycle considerations into product roadmaps by exploring recyclable materials and take-back programs where feasible, while balancing infection control imperatives. By following these recommendations, industry leaders can strengthen resilience, differentiate clinically, and create commercially compelling propositions across a range of end user settings.

A robust, multi-method research approach combining primary clinical insights, regulatory and patent analysis, and scenario-driven validation to support practical strategic decisions

The underlying research methodology integrates multiple evidence streams to deliver rigorous, defensible insights. Primary research included structured interviews and confidential consultations with clinical key opinion leaders, procurement directors, biomedical engineering leads, and supply chain executives to surface operational pain points, adoption criteria, and service expectations. Expert panels and advisory boards provided clinical context for emerging technologies and validated assumptions about procedural workflows and training requirements. These qualitative inputs were triangulated with secondary data drawn from peer-reviewed clinical literature, regulatory filings, patent landscapes, and device registries to ensure technical assertions and performance claims were corroborated.

Analytical methods incorporated scenario planning and sensitivity analysis to explore how variables such as tariff changes, reimbursement shifts, and technology adoption curves could affect strategic outcomes without producing market estimates. Competitive benchmarking employed product feature matrices, regulatory milestones, and public disclosures to map capability gaps and identify potential partnership pathways. Validation steps included cross-referencing interview findings with clinical trial outcomes, device safety databases, and manufacturing capacity indicators to reduce bias and enhance reliability. The geographic scope covered major regional markets with attention to regulatory nuances and distribution models, and the temporal scope reflected the most recent clinical and policy developments up to mid-2024.

Finally, findings were subject to internal peer review and editorial quality control to ensure clarity, accuracy, and practical relevance for commercial and clinical stakeholders seeking to make informed decisions in a dynamic environment.

Synthesis of clinical, operational, and strategic imperatives that underscore the importance of integrated product, supply chain, and evidence strategies for lasting impact

The cumulative picture for flexible gastrointestinal endoscopic devices is one of rapid technical progress intersecting with heightened operational and regulatory scrutiny. Advances in visualization modalities, insertion mechanics, and data analytics are improving clinical capabilities while simultaneously raising considerations around sterilization, supply resilience, and lifecycle economics. As healthcare providers and payers place greater emphasis on outcomes and efficiency, manufacturers must reconcile high-performance design with practical service models and diversified manufacturing strategies.

Strategically, the most successful participants will be those that deliver demonstrable clinical value, build resilient supply chains that mitigate trade and tariff risk, and adopt flexible commercialization channels aligned to the specific needs of hospitals, ambulatory surgical centers, and clinics. Evidence generation and training programs remain critical enablers of adoption, and proactive engagement with regulatory and standards bodies can reduce friction for both reusable and single-use solutions. For clinical leaders, the imperative is to balance innovation adoption with robust infection prevention and cost-control mechanisms.

Ultimately, the market rewards solutions that treat devices as part of an integrated care pathway rather than standalone instruments. Organizations that align product development, manufacturing, clinical evidence, and commercial execution around this systems perspective will be best positioned to capitalize on technological advances while navigating operational headwinds.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Flexible Gastrointestinal Endoscopic Devices Market, by Device Type

  • 8.1. Colonoscopes
  • 8.2. Duodenoscopes
  • 8.3. Enteroscopes
  • 8.4. Gastroscopes

9. Flexible Gastrointestinal Endoscopic Devices Market, by Endoscopy Type

  • 9.1. Diagnostic
    • 9.1.1. Biopsy
    • 9.1.2. Imaging
  • 9.2. Therapeutic
    • 9.2.1. Hemostasis
    • 9.2.2. Polypectomy
    • 9.2.3. Stent Placement
    • 9.2.4. Variceal Ligation

10. Flexible Gastrointestinal Endoscopic Devices Market, by Technology

  • 10.1. Insertion Technology
    • 10.1.1. Motorized Insertion
    • 10.1.2. Standard Insertion
  • 10.2. Visualization Technology
    • 10.2.1. 4K Imaging
    • 10.2.2. Autofluorescence
    • 10.2.3. High Definition
    • 10.2.4. Narrow Band Imaging

11. Flexible Gastrointestinal Endoscopic Devices Market, by Applications

  • 11.1. Diagnostic Imaging
  • 11.2. Foreign Body Removal
  • 11.3. Hemorrhage Control
  • 11.4. Polyp Detection
  • 11.5. Stricture Dilation
  • 11.6. Tissue Biopsy

12. Flexible Gastrointestinal Endoscopic Devices Market, by End Users

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Clinics
  • 12.3. Hospitals

13. Flexible Gastrointestinal Endoscopic Devices Market, by Sales Channel

  • 13.1. Direct Sales
  • 13.2. Distributors
  • 13.3. E-Commerce

14. Flexible Gastrointestinal Endoscopic Devices Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Flexible Gastrointestinal Endoscopic Devices Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Flexible Gastrointestinal Endoscopic Devices Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Flexible Gastrointestinal Endoscopic Devices Market

18. China Flexible Gastrointestinal Endoscopic Devices Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Ambu A/S
  • 19.6. ATMOS MedizinTechnik GmbH & Co. KG
  • 19.7. Becton, Dickinson and Company
  • 19.8. Boston Scientific Corporation
  • 19.9. ConMed Corporation
  • 19.10. Cook Medical LLC
  • 19.11. EndoMed Systems GmbH
  • 19.12. Erbe Elektromedizin GmbH
  • 19.13. Fujifilm Holdings Corporation
  • 19.14. HOYA Corporation
  • 19.15. Johnson & Johnson
  • 19.16. KARL STORZ SE & Co. KG
  • 19.17. Laborie Medical
  • 19.18. Medtronic plc
  • 19.19. Olympus Corporation
  • 19.20. Richard Wolf GmbH
  • 19.21. Smith & Nephew plc
  • 19.22. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLONOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLONOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COLONOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DUODENOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DUODENOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DUODENOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENTEROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENTEROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENTEROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY GASTROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY GASTROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY GASTROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY BIOPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HEMOSTASIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HEMOSTASIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HEMOSTASIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY POLYPECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY POLYPECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY POLYPECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STENT PLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STENT PLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STENT PLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VARICEAL LIGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VARICEAL LIGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VARICEAL LIGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY MOTORIZED INSERTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY MOTORIZED INSERTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY MOTORIZED INSERTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STANDARD INSERTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STANDARD INSERTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STANDARD INSERTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY 4K IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY 4K IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY 4K IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY AUTOFLUORESCENCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY AUTOFLUORESCENCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY AUTOFLUORESCENCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HIGH DEFINITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HIGH DEFINITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HIGH DEFINITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY NARROW BAND IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY NARROW BAND IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY NARROW BAND IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FOREIGN BODY REMOVAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FOREIGN BODY REMOVAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY FOREIGN BODY REMOVAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HEMORRHAGE CONTROL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HEMORRHAGE CONTROL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HEMORRHAGE CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY POLYP DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY POLYP DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY POLYP DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STRICTURE DILATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STRICTURE DILATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY STRICTURE DILATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TISSUE BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TISSUE BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY E-COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. GCC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. GCC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. GCC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. GCC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 213. GCC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 214. GCC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. GCC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 216. GCC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. GCC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 218. GCC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 219. GCC FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 242. G7 FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 243. G7 FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. G7 FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. G7 FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 246. G7 FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 247. G7 FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 248. G7 FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 249. G7 FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 250. G7 FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 251. G7 FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 252. G7 FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 253. NATO FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 254. NATO FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. NATO FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY ENDOSCOPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. NATO FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 257. NATO FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 258. NATO FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 259. NATO FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY INSERTION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 260. NATO FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 261. NATO FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 262. NATO FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 263. NATO FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 264. GLOBAL FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES FLEXIBLE GASTROINTESTINAL ENDOSCOPIC DEVICES MARKET SIZE, 2018-2032 (USD